Modulation of Inflammatory Responses by a Cannabinoid-2–Selective Agonist after Spinal Cord Injury

Chemokines as Possible Targets in Modulation of the Secondary Damage After Acute Spinal Cord Injury: A Review

(2009) Peter Gál et al.   CELLULAR AND MOLECULAR NEUROBIOLOGY

Modulation of Cannabinoid Receptor Activation as a Neuroprotective Strategy for EAE and Stroke

(2009) Ming Zhang et al.   Journal of Neuroimmune Pharmacology

CB2 receptor activation attenuates microcirculatory dysfunction during cerebral ischemic/reperfusion injury

(2009) Ming Zhang et al.   MICROVASCULAR RESEARCH

The interplay between the immune and central nervous systems in neuronal injury

(2009) V. W. Yong et al.   NEUROLOGY

Dynamics of the inflammatory response after murine spinal cord injury revealed by flow cytometry

(2008) David P. Stirling et al.   JOURNAL OF NEUROSCIENCE RESEARCH

Cannabinoid CB2receptors: a therapeutic target for the treatment of inflammatory and neuropathic pain

(2007) J Guindon et al.   BRITISH JOURNAL OF PHARMACOLOGY

Direct suppression of autoreactive lymphocytes in the central nervous system via the CB2receptor

(2007) B N Dittel   BRITISH JOURNAL OF PHARMACOLOGY

CB2receptors in the brain: role in central immune function

(2007) G A Cabral et al.   BRITISH JOURNAL OF PHARMACOLOGY

Inflammation and its role in neuroprotection, axonal regeneration and functional recovery after spinal cord injury

(2007) Dustin J. Donnelly et al.   EXPERIMENTAL NEUROLOGY